• Clinical Trials & Research

    Dr. Kim Stegmaier

    Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center collaborate with doctors and researchers around the world to provide advanced care in more specialties and subspecialties, more expertise in every facet of care for cancer and blood disorders, and more cutting-edge treatment options. Thanks in part to these collaborations, we're introducing promising new drugs and opening worldwide clinical trials that break new ground across the spectrum of cancer and blood disorders — like our protocols targeted for relapsed acute lymphoblastic leukemia, molecular profiling of brainstem gliomas, bone marrow transplantation for dyskeratosis congenita, and immunotherapy for relapsed neuroblastoma.

    Our Current Trials

    At any given time we are sponsoring and collaborating on over 100 pediatric cancer and blood disorder clinical trials. Download a PDF summary of our current trials, or search for trials by keyword, or follow the links below to find trials in your area of interest. For more information, email us at clinicaltrials@danafarberbostonchildrens.org.

    Blood Disorder (Hematology) Clinical Trials

    Brain Tumor Clinical Trials

    Histiocytosis Clinical Trials

    Leukemia Clinical Trials

    Lymphoma Clinical Trials

    Solid Tumor Clinical Trials

    Stem Cell Transplant and Gene Therapy Clinical Trials

  • PDF: Current Clinical Trials

    Download a PDF summary that lists most of our current clinical trials. 
  • Get Clinical Trial Updates


    Stay informed about our clinical trials and ongoing research. Sign up to receive our email newsletter.

  • Precision Cancer Medicine

    Precision cancer medicine provides individualized treatment tailored to the specific genetic characteristics of a patient's cancer. Our research and clinical trials are leading the way in precision medicine for pediatric cancer.
  • Outstanding Care

    Dr. Stuart Orkin, Chair of Pediatric Oncology, describes the unparalleled resources available at Dana-Farber/Boston Children's.